Besides, the ULK1 activator LYN-1604, which can induce autophagy-related cell death through the ULK complex, shows significant anticancer activity in triple-negative breast cancer (Ouyang et al., 2017). This evidence concerns the gene LYN and triple-negative breast carcinoma.